RedHill Biopharma Ltd.

NasdaqCM:RDHL Stock Report

Market Cap: US$15.2m

RedHill Biopharma Ltd. Company Information

RedHill Biopharma Ltd.'s employee growth, exchange listings and data sources


Key Information

  • Name: RedHill Biopharma Ltd.
  • Ticker: RDHL
  • Exchange: NasdaqCM
  • Founded: 2009
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$15.211m
  • Shares Outstanding: 29.70m
  • Website: https://www.redhillbio.com

Number of Employees


Location

  • RedHill Biopharma Ltd.
  • 21 Ha’arba’a Street
  • Tel Aviv
  • 6473921
  • Israel


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
RDHLNasdaqCM (Nasdaq Capital Market)YesSPONSORED ADSUSUSDDec 2012
2RH0DB (Deutsche Boerse AG)YesSPONSORED ADSDEEURDec 2012

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/03/27 00:00
End of Day Share Price 2024/03/27 00:00
Earnings2023/06/30
Annual Earnings2022/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.